GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica

Background We previously reported the association between blood–brain barrier (BBB) dysfunction and glucose‐regulated protein 78 (GRP 78) autoantibodies in neuromyelitis optica (NMO).